首页> 外国专利> cd8 + human dendritic cell (dcir) immunoreceptor-mediated cross sensitization

cd8 + human dendritic cell (dcir) immunoreceptor-mediated cross sensitization

机译:cd8 +人类树突状细胞(dcir)免疫受体介导的交叉致敏

摘要

cross-mediated dendritic cell (dcir) immunoreceptors of cd8 + t human cells. immunostimulant compositions and methods comprising a potent cross-presentation immunoreceptor (dcir) containing motif thereof are described herein. The inventors evaluated human cd8 + t-cell responses generated by segmenting dendritic cell (dc) antigens across various lectin receptors. a single exposure to a low dose of anti-dcir antigen-conjugated dcir-initiated human t cell immunity-specific cd8 + antigen by all dc ex vivo subsets including dcs generated, isolated skin, blood and mdcs langerhans cells and pdc. Improved cd8 + specific t-cell responses were observed when antigens such as, squirting, mart-1, viral (hiv gag), etc. were delivered to dcs via dcir, compared to those induced by free antigen, or to a mab-conjugated antigen. control or delivered via dc-sign, another lectin receptor. In addition to toll-like receptor (TLR) cross-presentation 7/8-agonist enhanced mediated dcir as well as crosspriming. thus, the target antigen via the human dcir receptor enables activation of specific cd8 + t cell immunity.
机译:交叉介导的cd8 + t人类细胞的树突状细胞(dcir)免疫受体。本文描述了包含其基序的有效交叉呈递免疫受体(dcir)的免疫刺激组合物和方法。发明人评估了通过跨各种凝集素受体分割树突细胞(dc)抗原而产生的人cd8 + t细胞应答。所有直流离体子集(包括产生的DC,分离的皮肤,血液和MDC Langerhans细胞和PDC)一次暴露于低剂量的抗DCir抗原偶联的dcir引发的人t细胞免疫特异性cd8 +抗原。与自由抗原诱导的抗原或单克隆抗体偶联的抗原相比,当抗原(如喷出,mart-1,病毒(HIV gag)等)通过dcir传递至dcs时,观察到了cd8 +特异性t细胞应答的改善。抗原。通过另一种凝集素受体dc-sign控制或递送。除了收费样受体(TLR),交叉呈递7/8激动剂还增强了介导的dcir以及交叉引物。因此,通过人dcir受体的靶抗原能够激活特定的cd8 + t细胞免疫。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号